After Eighty Study
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The rationale of the present clinical trial is to study whether an invasive strategy in clinical stable patients over 80 years with NSTEMI/UAP may improve rates of death, reinfarction, stroke, need of urgent revascularisation, myocardial function and quality of life. The invasive approach involves coronary angiography with immediate evaluation for three different treatment options; 1. Percutaneous coronary intervention (PCI), 2. Coronary artery bypass graft (CABG) or 3. medical treatment. Clinical practice shows that older patients are commonly treated less vigorously than younger patients and the present guidelines are based on a considerably younger population.
| Condition |
|---|
|
Coronary Heart Disease |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Prospective |
| Official Title: | A Randomised Prospective Study of an Invasive Strategy Versus Medical Therapy in Patients Over 80 Years With Non ST-Elevation Myocardial Infarction (NSTEMI) or Unstable Angina Pectoris (UAP) |
- Composite endpoints. [ Time Frame: One year follow up. ] [ Designated as safety issue: No ]Does an invasive strategy in clinical stable patients over 80 years with NSTEMI/UAP improve rates of death, reinfarction, stroke and need of urgent revascularisation?
- Death of any cause [ Time Frame: One year from randomization ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 492 |
| Study Start Date: | September 2010 |
Eligibility| Ages Eligible for Study: | 80 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Multicenter study
Inclusion Criteria:
- Age ≥ 80 years.
- Acute coronary syndrome (NSTEMI/UAP) with chest pain > 10 minutes, with or without ST-segment depression in ECG, and normal or elevated levels of troponin T or I. Elevated troponin levels are defined as values exceeding the 99 percentile of a normal population at the local laboratory at each participating site.
- Clinical stable
Exclusion Criteria:
- Age < 80 years.
- ST-segment elevation in ECG (STEMI)
- Clinical unstable with ongoing chest pain or other ischaemic symptoms/signs.
- Cardiogenic shock.
- Short life expectancy due to extra cardiac reason, ie. COPD, disseminated malignant disease, or other reason.
- Anamnestic indications for significant mental disorder, including dementia.
- Any condition which interferes with patients possibility to comply with protocol.
Contacts and Locations| Contact: Bjørn Bendz, MD PhD (chairman) | +47-95802582 | Bjorn.Bendz@oslo-universitetssykehus.no |
| Contact: Nicolai K. Tegn, PhD student | +47-98696554 | n.k.tegn@gmail.com |
| Norway | |
| Oslo University Hospital, Rikshospitalet | Recruiting |
| Oslo, Norway | |
| Contact: Bjørn Bendz, PhD +4795802582 Bjorn.Bendz@oslo-universitetssykehus.no | |
| Contact: Nicolai K. Tegn, PhD student +4798696554 n.k.tegn@gmail.com | |
More Information
No publications provided
| Responsible Party: | Bjørn Bendz, Rikshospitalet, Oslo University Hospital |
| ClinicalTrials.gov Identifier: | NCT01255540 History of Changes |
| Other Study ID Numbers: | 08/326b |
| Study First Received: | December 6, 2010 |
| Last Updated: | May 9, 2012 |
| Health Authority: | Regional Ethics Commitee:Norway |
Keywords provided by Oslo University Hospital:
|
Coronary heart disease in patients over 80 years of age. |
Additional relevant MeSH terms:
|
Angina, Unstable Coronary Artery Disease Myocardial Ischemia Coronary Disease Heart Diseases Myocardial Infarction Angina Pectoris |
Cardiovascular Diseases Vascular Diseases Chest Pain Pain Signs and Symptoms Arteriosclerosis Arterial Occlusive Diseases |
ClinicalTrials.gov processed this record on May 22, 2013